Profiel
Charles J.
Democko currently works at Vigil Neuroscience, Inc., as Senior VP-Regulatory Affairs & Quality from 2024.
Mr. Democko also formerly worked at Connetics Corp., as Vice President-Regulatory Affairs, Humanigen, Inc., as Vice President-Regulatory Affairs & Quality from 2008 to 2014, Signature Therapeutics, Inc., as Vice President-Regulatory Affairs & Development, Novacea, Inc., as Vice President-Regulatory Affairs, CytomX Therapeutics, Inc., as Vice President-Regulatory Affairs & Quality, and Catalyst Biosciences, Inc., as Senior Vice President-Regulatory Affairs.
Mr. Democko received his undergraduate degree from The Ohio State University and Masters Business Admin degree from San Francisco State University.
Actieve functies van Charles J. Democko
| Bedrijven | Functie | Begin |
|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Algemeen Adviseur | 01-09-2024 |
Eerdere bekende functies van Charles J. Democko
| Bedrijven | Functie | Einde |
|---|---|---|
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Algemeen Adviseur | 03-02-2009 |
| CYTOMX THERAPEUTICS, INC. | Public Communications Contact | - |
| CATALYST BIOSCIENCES | Public Communications Contact | - |
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Algemeen Adviseur | - |
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Algemeen Adviseur | - |
Opleiding van Charles J. Democko
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
Humanigen, Inc.
Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Francisco State University
San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Catalyst Biosciences, Inc.
Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
















